Literature DB >> 15640818

Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.

N Bunin1, R Aplenc, R Iannone, A Leahey, S Grupp, D Monos, G Pierson.   

Abstract

Both increased graft rejection and increased graft vs host disease (GVHD) remain obstacles to success for unrelated donor (URD) BMT for patients with SAA. Partial T cell depletion (PTCD) may decrease the risk of severe GVHD, while still maintaining sufficient donor T lymphocytes to ensure engraftment. We report on 12 patients with SAA who underwent PTCD URD BMT. All patients had failed medical therapy or relapsed following initial responses, and were transfusion dependent. The median age was 6 years, and there were five males. Donors were matched for four patients, and mismatched for eight. All patients received total body irradiation with either Ara-C or thiotepa and cyclophosphamide. PTCD was accomplished using monoclonal antibody T10B9 or OKT3 and complement. All patients engrafted, with a median time of 18 days to ANC >500. Only one patient had greater than grade II acute GVHD; two patients had limited and one patient extensive chronic GVHD. Nine patients are alive and transfusion independent at a median months post BMT. Three patients died from infection or renal failure. This series suggests that an aggressive immunosuppressive conditioning regimen with PTCD results in successful engraftment and minimal GVHD in pediatric patients with SAA, even with HLA mismatched donors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640818     DOI: 10.1038/sj.bmt.1704803

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

Review 1.  Current landscape for T-cell targeting in autoimmunity and transplantation.

Authors:  Daniel R Getts; Sushma Shankar; Emily M L Chastain; Aaron Martin; Meghann Teague Getts; Kathryn Wood; Stephen D Miller
Journal:  Immunotherapy       Date:  2011-07       Impact factor: 4.196

2.  Aneurysmal lesions of patients with abdominal aortic aneurysm contain clonally expanded T cells.

Authors:  Song Lu; John V White; Wan Lu Lin; Xiaoying Zhang; Charalambos Solomides; Kyle Evans; Nectaria Ntaoula; Ifeyinwa Nwaneshiudu; John Gaughan; Dimitri S Monos; Emilia L Oleszak; Chris D Platsoucas
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

3.  Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy.

Authors:  H Joachim Deeg; Margaret O'Donnell; Jakub Tolar; Rajni Agarwal; Richard E Harris; Stephen A Feig; Mary C Territo; Robert H Collins; Peter A McSweeney; Edward A Copelan; Shakila P Khan; Ann Woolfrey; Barry Storer
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

Review 4.  Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors:  Neal S Young; Rodrigo T Calado; Phillip Scheinberg
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

Review 5.  Acquired aplastic anemia in children.

Authors:  Helge D Hartung; Timothy S Olson; Monica Bessler
Journal:  Pediatr Clin North Am       Date:  2013-10-16       Impact factor: 3.278

Review 6.  Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.

Authors:  Frank Peinemann; Ulrich Grouven; Nicolaus Kröger; Max Pittler; Beate Zschorlich; Stefan Lange
Journal:  Haematologica       Date:  2009-07-31       Impact factor: 9.941

7.  Outcomes of matched sibling and alternative donor stem cell transplantation for 26 children with severe aplastic anemia.

Authors:  Ming-Yun Hsieh; Tzeon-Jye Chiou; Giun-Yi Hung; Hsiu-Ju Yen
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

8.  Clonally expanded alpha-chain T-cell receptor (TCR) transcripts are present in aneurysmal lesions of patients with Abdominal Aortic Aneurysm (AAA).

Authors:  Song Lu; John V White; Raquel I Judy; Lisa L Merritt; Wan Lu Lin; Xiaoying Zhang; Charalambos Solomides; Ifeyinwa Nwaneshiudu; John Gaughan; Dimitri S Monos; Emilia L Oleszak; Chris D Platsoucas
Journal:  PLoS One       Date:  2019-07-16       Impact factor: 3.240

9.  T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejection.

Authors:  Thomas H Waid; John S Thompson; Maria Siemionow; Stephen A Brown
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.